RESOURCES
 
LOG IN
SIGN-UP
SEARCH
JUMP TO ADVANCED SEARCH
                                            
The Cyclotron Facility manufactures radiopharmaceuticals to be used in the detection of disease using positron emission tomography.
Welcome to the Genomics Sector Innovation Network (G-SIN) portal

The Cyclotron Facility manufactures radiopharmaceuticals to be used in the detection of disease using positron emission tomography.
EXPLORE >   Resources >  Cyclotron
Cyclotron
OVERVIEW
ACCESS
USE
TEAM
INTELLECTUAL PROPERTY
Overview
The Cyclotron Facility, opened in 2009 in London, Ontario, offers the most advanced equipment housed in a 6000 sq. ft. manufacturing facility. A cyclotron is a type of compact particle accelerator used to produce radioactive isotopes called positron emitters. Stable, non-radioactive isotopes are put into the cyclotron where they then react with a beam to form radioactive isotopes. These radioactive isotopes are then taken from the cyclotron, transformed into positron-emitting radiopharmaceuticals (PERs) within the facility’s laboratories. PERs are used for an imaging procedure on patients called positron emission tomography (PET). PET is used in many medical diagnostic applications including early and accurate detection of cancer and detecting certain diseases of the heart and brain. In combination with the PET/CT, PET/MRI, preclinical PET imaging scanners, the cyclotron facility is available to support a wide variety of research projects including PET imaging applied to oncology, cardiology, neurology, psychology, bioelectromagnetics, and other areas. This new Cyclotron Facility allows imaging researchers in London to remain at the forefront of hybrid imaging and facilitates the discovery of new radiopharmaceuticals in order to improve understanding, prevention and treatment of various diseases. This leading edge medical imaging is then used to drive the commercialization of new discoveries. The Cyclotron Facility has been funded by the Canada Foundation of Innovation (CFI), through the Biomedical Multimodality Hybrid Imaging project, with the balance of the funding coming from private sector partners.
Resource Information
Website
Send a message
Log In to mark favourites


Access
The equipment in the facility includes a GE PETtrace 8 cyclotron, cGMP specification class 100 shielded hot cells for production and dispensing, dedicated automated chemistry units for producing 18F and 11C radiopharmaceuticals to cGMP specifications, availability of 13N ammonia and 15O tracers, cGMP validated quality control instrumentation, and synthetic organic chemistry laboratory space.
Resource Information


Team


Contributor Role In Resource Organization Country
Michael Kovacs
Key Resource Personnel Not specified Canada


Intellectual Property

YOU MAY ALSO BE INTERESTED IN:


CATEGORIES
Application Area
Human health, Instrumentation and tools
Resource Type
Facilities and Infrastructure
Organism
Human, Non-human primate, Rodent
Sign-up to edit this profile
Events Jobs What is Genomics Genomics in Canada About Us Contact Us Privacy Policy Terms of Use Site-Map
© Ontario Genomics Institute, 2007-2014.